Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2007 1
2008 2
2009 1
2010 4
2011 1
2012 6
2013 8
2014 7
2015 6
2016 8
2017 7
2018 12
2019 9
2020 15
2021 14
2022 14
2023 11
2024 17
2025 14
2026 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.
Colson AE, Kumar PN, Ruane PJ, Chetchotisakd P, Ratanasuwan W, Liberty A, Nahass RG, Arenas-Pinto A, Post FA, Baker DA, Cahn P, Hofmann E, Watanabe D, Lu PL, Roukens AHE, Parczewski M, Wang H, Chen K, Shihadeh F, Shaughnessy M, Dvory-Sobol H, SenGupta D, Llamoso C, Rhee M, Ogbuagu O; ISLEND-2 Study Team. Colson AE, et al. Lancet. 2026 Aug 29;408(10557):821-832. doi: 10.1016/S0140-6736(26)01442-X. Epub 2026 Aug 12. Lancet. 2026. PMID: 42586113 Clinical Trial.
Phase 3 Trial of Weekly Oral Islatravir-Lenacapavir for HIV-1 Treatment.
Rockstroh JK, Ramgopal MN, Curran Fàbregas A, Hedgcock M, Workowski KA, Ronot-Bregigeon S, Cassetti I, Brinson C, Gupta SK, Hung CC, O'Reilly M, Slim J, Gatanaga H, Shalit P, Liu SY, Klopfer SO, Shihadeh F, Patel N, Mercier RC, Shaughnessy M, Dvory-Sobol H, SenGupta D, Llamoso C, Rhee MS, Orkin C; ISLEND-1 Study Team. Rockstroh JK, et al. N Engl J Med. 2026 Oct 1;395(13):1299-1309. doi: 10.1056/NEJMoa2607973. Epub 2026 Jul 29. N Engl J Med. 2026. PMID: 42525925 Clinical Trial.
Mpox in people with advanced HIV infection: a global case series.
Mitjà O, Alemany A, Marks M, Lezama Mora JI, Rodríguez-Aldama JC, Torres Silva MS, Corral Herrera EA, Crabtree-Ramirez B, Blanco JL, Girometti N, Mazzotta V, Hazra A, Silva M, Montenegro-Idrogo JJ, Gebo K, Ghosn J, Peña Vázquez MF, Matos Prado E, Unigwe U, Villar-García J, Wald-Dickler N, Zucker J, Paredes R, Calmy A, Waters L, Galvan-Casas C, Walmsley S, Orkin CM; SHARE-NET writing group. Mitjà O, et al. Lancet. 2023 Mar 18;401(10380):939-949. doi: 10.1016/S0140-6736(23)00273-8. Epub 2023 Feb 21. Lancet. 2023. PMID: 36828001
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection.
Preechanukul A, Alrubayyi A, Sun B, Arbe-Barnes E, Kokici J, Gorou F, Prasitdumrong S, da Costa KAS, Fisher-Pearson N, Hussain N, Kucykowicz S, Ghosh I, Burns F, Kinloch S, Simoes P, Bhagani S, Kennedy PTF, Maini MK, Bashford-Rogers R, Gill US, Peppa D. Preechanukul A, et al. Among authors: simoes p. Gut. 2026 Jun 9;75(7):1397-1410. doi: 10.1136/gutjnl-2025-335461. Gut. 2026. PMID: 41344698 Free PMC article.
Favism: A Case Report.
Diegues A, Simões P, Ceriz T, Lopes AR, Tomé E. Diegues A, et al. Among authors: simoes p. Cureus. 2022 Mar 17;14(3):e23269. doi: 10.7759/cureus.23269. eCollection 2022 Mar. Cureus. 2022. PMID: 35449616 Free PMC article.
Enantiorecognition in a multi-component environment.
Mazurkiewicz J, Stanek E, Maximiano P, Ferreira TH, Karpiel M, Buda S, Kalinowska-Tłuścik J, Simões PN, Reva I, Kaczor A. Mazurkiewicz J, et al. Among authors: simoes pn. Phys Chem Chem Phys. 2025 Feb 27;27(9):4905-4914. doi: 10.1039/d5cp00022j. Phys Chem Chem Phys. 2025. PMID: 39960761
Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study.
Fink DL, Callaby H, Luintel A, Beynon W, Bond H, Lim EY, Gkrania-Klotsas E, Heskin J, Bracchi M, Rathish B, Milligan I, O'Hara G, Rimmer S, Peters JR, Payne L, Mody N, Hodgson B, Lewthwaite P, Lester R, Woolley SD, Sturdy A, Whittington A, Johnson L, Jacobs N, Quartey J, Ai Payne B, Crowe S, Elliott IA, Harrison T, Cole J, Beard K, Cusack TP, Jones I, Banerjee R, Rampling T; Specialist and High Consequence Infectious Diseases Centres Network for Monkeypox; Dunning J. Fink DL, et al. Lancet Infect Dis. 2023 May;23(5):589-597. doi: 10.1016/S1473-3099(22)00806-4. Epub 2022 Dec 22. Lancet Infect Dis. 2023. PMID: 36566771 Free article.
Experimental Evolution in a Warming World: The Omics Era.
Santos MA, Carromeu-Santos A, Quina AS, Antunes MA, Kristensen TN, Santos M, Matos M, Fragata I, Simões P. Santos MA, et al. Among authors: simoes p. Mol Biol Evol. 2024 Aug 2;41(8):msae148. doi: 10.1093/molbev/msae148. Mol Biol Evol. 2024. PMID: 39034684 Free PMC article. Review.
EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study.
Martins-Branco D, Lobo-Martins S, Aftimos P, Pereira B, Vasconcelos de Matos L, Fernandes L, Campôa E, Nader-Marta G, Moreau M, Taylor D, Duhoux FP, Simões P, Garcia AR, Patel V, Confente C, Alpuim Costa D, Pereira J, Santos C, Paesmans M, Sarmento F, Gantes Padrão T, Simão D, Bandarra D, Sousa B, Brito M, Gombos A, Ameye L, de Azambuja E. Martins-Branco D, et al. Among authors: simoes p. Breast Cancer Res Treat. 2026 Jul 10;218(1):7. doi: 10.1007/s10549-026-08012-5. Breast Cancer Res Treat. 2026. PMID: 42429895
159 results